β-amyloid cytotoxicity is prevented by natural achillolide A
Open accessAbstract
Alzheimer's disease (AD) is the most prevalent cause of dementia in adults. Current available drugs for AD transiently alleviate some of the symptoms, but do not modify the disease mechanism or cure it. Therefore, new drugs are desperately needed. Key contributors to AD are amyloid beta (Aβ)- and reactive oxygen species (ROS)-induced cytotoxicities. Plant-derived substances have been shown to affect various potential targets in various diseases including AD. Therefore, phytochemicals which can protect neuronal cells against these insults might help in preventing and treating this disease. In the following research, we have isolated the sesquiterpene lactone achillolide A from the plant Achillea fragrantissima and, for the first time, characterized its effects on Aβ-treated neuroblastoma cells. Aβ is a peptide derived from the sequential cleavage of amyloid precursor protein, and is part of the pathogenesis of AD. Our current study aimed to determine whether achillolide A can interfere with Aβ-induced processes in Neuro2a cells, and protect them from its toxicity. Our results show that achillolide A decreased Aβ-induced death and enhanced the viability of Neuro2a cells. In addition, achillolide A reduced the accumulation of Aβ-induced ROS and inhibited the phosphorylation of stress-activated protein kinase/c-Jun N-terminal kinase and p44/42 mitogen-activated protein kinase in these cells. We therefore suggest that achillolide A may have therapeutic potential for the treatment of AD.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cytotoxicity of neuroblastoma cells by Aβ deposition decreased significantly by sesquiterpene lactones.
“In addition, the cytotoxicity of neuroblastoma cells by Aβ deposition decreased significantly by sesquiterpene lactones [63].”
From Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer’s Disease Therapy (2021) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
Cuevas, E., Lantz, S. M., Tobón-Velasco, J. C., Newport, G. D., Wu, Q., Virmani, A., Ali, S. F., & Santamarı́a, A. (2011) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2010.12.002 · Cited by 26 · see citing works
RetractedAlzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063 · see citing works
Quantification of cells cultured on 96-well plates
Kueng, W., Silber, E., & Eppenberger, U. (1989) · Analytical Biochemistry · doi:10.1016/0003-2697(89)90710-0 · Cited by 641 · see citing works
Jiang, T., Sun, Q., & Chen, S. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.07.005 · Cited by 594 · see citing works
Prata, C., Zambonin, L., Rizzo, B., Maraldi, T., Angeloni, C., Sega, F. V. D., Fiorentini, D., & Hrelia, S. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3724545 · Cited by 540 · see citing works
Williams, R. J., & Spencer, J. P. E. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.010 · Cited by 448 · see citing works
Savage, M. J., Lin, Y.-G., Ciallella, J. R., Flood, D. G., & Scott, R. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03376.2002 · Cited by 291 · see citing works
Neuroprotective effect of natural products against Alzheimer’s disease
Essa, M. M., Vijayan, R. K., Castellano-Gonzalez, G., Memon, M. A., Braidy, N., & Guillemin, G. J. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0799-9 · Cited by 278 · see citing works
Perspectives on Sesquiterpene Lactones in Inflammation and Cancer
Merfort, I. (2011) · Current Drug Targets · doi:10.2174/138945011798109437 · Cited by 262 · see citing works
Flavonoids as Therapeutic Compounds Targeting Key Proteins Involved in Alzheimer’s Disease
Baptista, F. I., Henriques, A. G., Silva, A. M. S., Wiltfang, J., & Silva, O. A. B. D. C. E. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400213r · Cited by 189 · see citing works
Kaminsky, Y. G., Marlatt, M. W., Smith, M. A., & Kosenko, E. A. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.09.005 · Cited by 165 · see citing works
Herbal medicine in the treatment of Alzheimer's disease
Akhondzadeh, S., & Abbasi, S. H. (2006) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750602100211 · Cited by 153 · see citing works
Recent Updates in the Treatment of Neurodegenerative Disorders Using Natural Compounds
Rasool, M., Malik, A., Qureshi, M. S., Manan, A., Pushparaj, P. N., Asif, M., Qazi, M. H., Qazi, A. M., Kamal, M. A., Gan, S. H., et al. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/979730 · Cited by 124 · see citing works
The role of oxidative stress in anticancer activity of sesquiterpene lactones
Gach, K., Długosz-Pokorska, A., & Janecka, A. E. (2015) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-015-1096-3 · Cited by 112 · see citing works
Anti-Parkinsonian drug discovery from herbal medicines: What have we got from neurotoxic models?
Song, J., Sze, S. C. W., Ng, T., Lee, C., Leung, G., Shaw, P., Tong, Y., & Zhang, Y. (2011) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2011.12.030 · Cited by 102 · see citing works
Echeverrı́a, V., Ducatenzeiler, A., Dowd, E., Jänne, J., Grant, S. M., Szyf, M., Wandosell, F. G., Ávila, J., Grimm, H. S., Dunnett, S. B., et al. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.036 · Cited by 101 · see citing works
Kang, J. S., Yoon, Y. D., Lee, K. H., Park, S., & Kim, H. M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.109 · Cited by 99 · see citing works
Mechanisms of Action of Phytochemicals from Medicinal Herbs in the Treatment of Alzheimerʼs Disease
Kim, M. S., Kim, S., & Yang, W. M. (2014) · Planta Medica · doi:10.1055/s-0034-1383038 · Cited by 96 · see citing works
Activation of JNK Signaling Mediates Amyloid-ß-Dependent Cell Death
Tare, M., Modi, R. M., Nainaparampil, J. J., Puli, O. R., Bedi, S., Fernández-Fúnez, P., Kango‐Singh, M., & Singh, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024361 · Cited by 88 · see citing works
Inhibition of c-Jun kinase provides neuroprotection in a model of Alzheimer's disease
Braithwaite, S. P., Schmid, R. S., Dong, H., Sung, M.-L. A., Cho, S., Resnick, L., Monaghan, M. M., Hirst, W. D., Essrich, C., Reinhart, P. H., et al. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.04.015 · Cited by 82 · see citing works
Zeitlin, R., Patel, S., Burgess, S., Arendash, G. W., & Echeverrı́a, V. (2011) · Brain Research · doi:10.1016/j.brainres.2011.08.036 · Cited by 82 · see citing works
Flavonoids and Dementia: An Update
Orhan, İ. E., Daglia, M., Nabavi, S. F., Loizzo, M. R., Sobarzo‐Sánchez, E., & Nabavi, S. M. (2015) · Current Medicinal Chemistry · doi:10.2174/0929867322666141212122352 · Cited by 67 · see citing works
Antibody-Based Drugs and Approaches Against Amyloid-β Species for Alzheimer’s Disease Immunotherapy
Liu, J., Yang, B., Ke, J., Li, W., & Suen, W.-C. (2016) · Drugs & Aging · doi:10.1007/s40266-016-0406-x · Cited by 67 · see citing works
Huang, C., Lin, K., Cheng, Y., Hsu, C., Yang, S., & Shyur, L. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.01.013 · Cited by 63 · see citing works
Dong, L., Qiao, H., Zhang, X., Zhang, X., Wang, C., Wang, L., Cui, L., Zhao, J., Xing, Y., Lǐ, Y., et al. (2013) · Mediators of Inflammation · doi:10.1155/2013/370804 · Cited by 61 · see citing works
Li, H., Han, W., Wang, H., Ding, F., Xiao, L., Shi, R., Ai, L., & Huang, Z. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4517486 · Cited by 59 · see citing works
Chiu, K., Wu, C., Chia, C.-H., Hsu, S., & Tzeng, Y. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.046 · Cited by 58 · see citing works
Choi, E. M., Kim, G., & Lee, Y. S. (2009) · Toxicology in Vitro · doi:10.1016/j.tiv.2009.05.005 · Cited by 50 · see citing works
Liu, C., Hong, Z., Ji, Z.-H., & Yu, X. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1370-7 · Cited by 41 · see citing works
Amoah, S. K. S., Dalla Vecchia, M. T., Pedrini, B., Carnhelutti, G. L., Gonçalves, A. E., dos Santos, D. A., Biavatti, M. W., & de Souza, M. M. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.11.018 · Cited by 40 · see citing works
Ghasemi, R., Moosavi, M., Zarifkar, A., Rastegar, K., & Maghsoudi, N. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-015-0622-6 · Cited by 28 · see citing works
Kim, S., Cho, S., & Moon, H. (2010) · Phytotherapy Research · doi:10.1002/ptr.3277 · Cited by 26 · see citing works
Elmann, A., Telerman, A., Mordechay, S., Erlank, H., Rindner, M., Ofir, R., & Kashman, Y. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.09.003 · Cited by 15 · see citing works
Downregulation of Microglial Activation by Achillolide A
Elmann, A., Telerman, A., Mordechay, S., Erlank, H., Rindner, M., Kashman, Y., & Ofir, R. (2015) · Planta Medica · doi:10.1055/s-0034-1396204 · Cited by 12 · see citing works
Elmann, A., Telerman, A., Ofir, R., & Kashman, Y. (2017) · Journal of Molecular Neuroscience · doi:10.1007/s12031-017-0916-y · Cited by 12 · see citing works
Impact of a discordant helix on β-amyloid structure, aggregation ability and toxicity
Chen, Y.-C. (2017) · European Biophysics Journal · doi:10.1007/s00249-017-1235-5 · Cited by 11 · see citing works
Schwarz, D., Bloom, D., Castro, R., Pagán, O. R., & Jiménez‐Rivera, C. A. (2011) · Current Neuropharmacology · doi:10.2174/157015911795017010 · Cited by 9 · see citing works
Elmann, A., Telerman, A., Erlank, H., Ofir, R., Kashman, Y., & Beit‐Yannai, E. (2016) · Molecules · doi:10.3390/molecules21030301 · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Anti-Inflammatory and Immunoregulatory Action of Sesquiterpene Lactones
Paço, A., Brás, T., dos Santos, J. O., Sampaio, P., Gomes, A. C., & Duarte, M. F. (2022) · Molecules · doi:10.3390/molecules27031142 · Cited by 130 · see citing works
Arya, A., Chahal, R., Rao, R., Rahman, M. H., Kaushik, D., Akhtar, M. F., Saleem, A., Khalifa, S. M. A., El-Seedi, H. R., Kamel, M., et al. (2021) · Biomolecules · doi:10.3390/biom11030350 · Cited by 111 · see citing works
“In addition, the cytotoxicity of neuroblastoma cells by Aβ deposition decreased significantly by sesquiterpene lactones [63].”
BackgroundCerium oxide NPs mitigate the amyloid formation of α-synuclein and associated cytotoxicity
Zand, Z., Khaki, P. A., Salihi, A. B., Sharifi, M., Nanakali, N. M. Q., Al-Asady, A. A., Aziz, F. M., Shahpasand, K., Hasan, A., & Falahati, M. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s220380 · Cited by 62 · see citing works
Khodabandeh, A., Yakhchian, R., Hasan, A., Paray, B. A., Shahi, F., Rasti, B., Mirpour, M., Sharifi, M., Derakhshankhah, H., Akhtari, K., et al. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.113198 · Cited by 28 · see citing works
The key roles of organelles and ferroptosis in Alzheimerʼs disease
Long, H., Cheng, Y., Zhou, Z., Luo, H., Wen, D., & Gao, L. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25033 · Cited by 27 · see citing works
Dabbaghi, M. M., Fadaei, M. S., Goldoozian, M., Fadaei, M. R., Rahimi, V. B., & Askari, V. R. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102023 · Cited by 5 · see citing works
Pal, R., Mukherjee, S., Khan, A., Nathani, M., Maji, S., Tandey, R., Das, S., Patra, A., & Mandal, V. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03266-6 · Cited by 4 · see citing works
Cannabis-derived terpenes and flavonoids as potential pharmaceuticals
Ofir, R. (2021) · Israel Journal of Plant Sciences · doi:10.1163/22238980-bja10022 · Cited by 4 · see citing works
Verma, H., Yadav, A., Gangwar, P., Kaur, S., Kumar, P., Dhiman, M., & Mantha, A. K. (2025) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-025-01799-y · Cited by 3 · see citing works
Zeid, E. H. A., Emam, H. M., Abd-Allah, N. A., Sobh, M. S., Khamis, T., El-Attar, R. H., Abdel-Hamid, S. E., Rehan, I. F., Elnagar, A., Zigo, F., et al. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1746307 · Cited by 1 · see citing works
Telerman, A., Kashman, Y., Ofir, R., & Elmann, A. (2021) · Israel Journal of Plant Sciences · doi:10.1163/22238980-bja10035
Dewangan, B., Swain, P., Patra, S., Bodhe, P. R., Kulkarni, N., & Sahu, B. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5247243
Dewangan, B., Swain, P., Patra, S., Bodhe, P. R., Kulkarni, N., & Sahu, B. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00481k
Eleiwa, N. Z. H., Khairy, M. H., Ahmed, A. M., Metwally, M. M. M., Aty, A. I. A. E., & Zeid, E. H. A. (2026) · Future Journal of Pharmaceutical Sciences · doi:10.1186/s43094-026-01007-5
- Authors
- Elmann, A., Telerman, A., Ofir, R., Kashman, Y., & Lazarov, O.
- Affiliations
- Agricultural Research Organization (IL)
- Dead Sea and Arava Science Center (IL)
- Tel Aviv University (IL)
- University of Illinois Chicago (US)
- Corresponding author
- Elmann, Anat
- Venue
- Journal of Natural Medicines
- Published
- 2018-03-15
- Volume
- 72
- Issue
- 3
- Pages
- 626-631
- ISSN
- 1340-3443 (ISSN-L)
- 1861-0293
- PMC
- PMC5960475
- OpenAlex
- W2792542624
- Cited by
- 14
- References
- 38
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 1 · 2022: 2 · 2021: 3 · 2020: 1 · 2019: 1
- FWCI
- 0.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Natural Medicines (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- United States - Israel Binational Agricultural Research and Development Fund (IS-4473-11)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Sesquiterpenes and Asteraceae Studies
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Keywords
- amyloid-beta, Alzheimer's disease, sesquiterpene lactones, Achillea fragrantissima, neuroprotection, reactive oxygen species, JNK phosphorylation, MAPK signaling, neuroblastoma cells, cytotoxicity
- MeSH terms
- Alzheimer Disease, Humans, Plant Extracts, Sesquiterpenes, Amyloid beta-Peptides, Reactive Oxygen Species
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review